Endocrinpath

Wirkstoff: ALFALFA, BORAGE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, CEANOTHUS AMERICANUS LEAF, ANHYDROUS CITRIC ACID, FUCUS VESICULOSUS, GINKGO, SUS SCROFA ADRENAL GLAND, GLYCYRRHIZA GLABRA, CENTELLA ASIATICA, BOS TAURUS HYPOTHALAMUS, POTASSIUM PHOSPHATE, DIBASIC, SUS SCROFA PANCREAS, PHYTOLACCA AMERICANA ROOT, BOS TAURUS PITUITARY GLAND, SMILAX ORNATA ROOT, SILICON DIOXIDE, SYZYGIUM CUMINI SEED, TARAXACUM OFFICINALE, THYROID, BOVINE

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · ALFALFA 15 [hp_X]/mL, BORAGE 15 [hp_X]/mL, OYSTER SHELL CALCIUM CARBONATE, CRUDE 15 [hp_X]/mL, CEANOTHUS AMERICANUS LEAF 4 [hp_X]/mL, ANHYDROUS CITRIC ACID 15 [hp_X]/mL, FUCUS VESICULOSUS 15 [hp_X]/mL, GINKGO 15 [hp_X]/mL, SUS SCROFA ADRENAL GLAND 9 [hp_X]/mL, GLYCYRRHIZA GLABRA 15 [hp_X]/mL, CENTELLA ASIATICA 15 [hp_X]/mL, BOS TAURUS HYPOTHALAMUS 12 [hp_X]/mL, POTASSIUM PHOSPHATE, DIBASIC 15 [hp_X]/mL, SUS SCROFA PANCREAS 9 [hp_X]/mL, PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL, BOS TAURUS PITUITARY GLAND 12 [hp_X]/mL, SMILAX ORNATA ROOT 15 [hp_X]/mL, SILICON DIOXIDE 12 [hp_X]/mL, SYZYGIUM CUMINI SEED 4 [hp_X]/mL, TARAXACUM OFFICINALE 15 [hp_X]/mL, THYROID, BOVINE 9 [hp_X]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energetix Corporation

Geprüft 2026-10-09 · openFDA NDC